RCUS
Arcus Biosciences, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +18.2% ·
flujo de acciones +30.0% ·
nuevas posiciones netas +15.4%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +1 | 62.00M | $1.91B | +8 | −7 |
| Q1 2026 | 85 | -2 | 57.45M | $1.24B | +6 | −8 |
| Q4 2025 | 87 | -1 | 64.26M | $1.53B | +1 | −2 |
| Q3 2025 | 20 | +2 | 36.84M | $500.99M | +2 | — |
| Q2 2025 | 15 | -1 | 35.18M | $286.34M | — | −1 |
| Q1 2025 | 13 | +2 | 11.54M | $90.60M | +4 | −2 |
| Q4 2024 | 11 | 0 | 8.18M | $121.86M | +1 | −1 |
| Q3 2024 | 10 | 0 | 4.70M | $71.80M | — | — |
| Q2 2024 | 10 | — | 4.00M | $60.94M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 3.70M | +23.5% | $29.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 2.87M | +43.6% | $22.51M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.39M | +14.8% | $10.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.39M | +14.8% | $10.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.19M | +29.2% | $9.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.08M | Nuevo | $8.50M | 0.0% | New | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.08M | Nuevo | $8.50M | 0.0% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.08M | Nuevo | $8.50M | 0.0% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.08M | Nuevo | $8.50M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.08M | Nuevo | $8.50M | 0.0% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 377.10K | +4.6% | $2.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 377.10K | +4.6% | $2.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 298.42K | +103.4% | $2.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 204.00K | +1002.7% | $1.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 137.64K | Nuevo | $1.08M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 112.05K | Nuevo | $879,601 | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 112.05K | Nuevo | $879,601 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 90.95K | +253.9% | $713,989 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 90.95K | +253.9% | $713,989 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 90.95K | +253.9% | $713,989 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 90.95K | +253.9% | $713,989 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 90.95K | +253.9% | $713,989 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 56.04K | Nuevo | $439,922 | 0.0% | New | 1 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 34.07K | +10.1% | $268,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Wellington Management | $8.50M | 0.0% |
| Wellington Management | $8.50M | 0.0% |
| Wellington Management | $8.50M | 0.0% |
| Wellington Management | $8.50M | 0.0% |
| Wellington Management | $8.50M | 0.0% |
| Fisher Asset Management | $1.08M | 0.0% |
| Marshall Wace | $879,601 | 0.0% |
| Marshall Wace | $879,601 | 0.0% |
| D. E. Shaw & Co. | $439,922 | 0.0% |
Posición cerrada
| Adage Capital Partners | $6.60M | era 0.0% |
| Norges Bank | $506,915 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 209 tenedores, 119.00M acciones, $2.56B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.83K acc. · $84,810
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
24.7% de clase · Ver presentación original ante la SEC ↗